Cao Yuting, Huang Jinyuan, Fan Xiaoyin, Dai Yinmei
Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University/Beijing Maternal and Child Health Care Hospital, Beijing, China.
State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital / National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital) / Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education / Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology / National Clinical Key Specialty Construction Program, P. R. China (2023), Beijing, 100191, China.
Curr Stem Cell Res Ther. 2024 Dec 27. doi: 10.2174/011574888X329310241206105808.
Premature Ovarian Failure (POI), a prevalent gynecological, endocrine disease, significantly impairs the reproductive health of women of childbearing age and presents a formidable challenge to clinicians. Until now, there has been a lack of effective treatments to fundamentally improve ovarian function in patients with POI. Stem cell therapy has emerged as a promising treatment in the field of POI, with notable research progress achieved to date.
This review sought to analyze the current status and hotspots of research on stem cell therapy for POI, forecasting future directions through bibliometrics.
Research related to stem cell therapy for POI from 2000 to 2023 was searched in the Web of Science Core Collection (WOSCC) database by setting subject-term, and the literature was analyzed econometrically using VOSviewer, CiteSpace, and the R package "bibliometrix."
According to our search and screening strategy, 203 pieces of literature related to stem cell therapy for POI were obtained and analyzed. There is a marked annual increase in publications, with a particularly rapid ascent in recent years. China has become the most prolific country in this field, with 136 publications. Shanghai Jiao Tong University ranked first among many universities and institutions in terms of the number of publications and citations. Stem Cell Research & Therapy was the most popular and influential journal in the field of stem cell therapy for POI. Lai Dongmei has published the most papers, while Liu Te boasts the highest frequency of co-citations. Investigation into the mechanisms of exosomes derived from stem cells and their associated signaling pathways is anticipated to be a crucial research topic in stem cell therapy for POI.
This review offers the first comprehensive and systematic analysis of the field of stem cell therapy for POI, with a visual representation of the findings. By summarizing the current status and projecting forthcoming trends, this study aims to offer guidance and a reference for scholars in the field.
卵巢早衰(POI)是一种常见的妇科内分泌疾病,严重损害育龄期女性的生殖健康,给临床医生带来巨大挑战。迄今为止,缺乏有效的治疗方法从根本上改善POI患者的卵巢功能。干细胞疗法已成为POI领域一种有前景的治疗方法,迄今已取得显著的研究进展。
本综述旨在分析POI干细胞治疗的研究现状和热点,通过文献计量学预测未来方向。
在Web of Science核心合集(WOSCC)数据库中通过设置主题词搜索2000年至2023年与POI干细胞治疗相关的研究,并使用VOSviewer、CiteSpace和R包“bibliometrix”对文献进行计量分析。
根据我们的检索和筛选策略,获得并分析了203篇与POI干细胞治疗相关的文献。出版物数量呈显著的年度增长,近年来增长尤为迅速。中国已成为该领域发文量最多的国家,有136篇出版物。上海交通大学在众多高校和机构中出版物数量和被引频次排名第一。《干细胞研究与治疗》是POI干细胞治疗领域最受欢迎和最具影响力的期刊。赖冬枚发表的论文最多,而刘特的共被引频次最高。对干细胞来源的外泌体及其相关信号通路机制的研究有望成为POI干细胞治疗的关键研究课题。
本综述首次对POI干细胞治疗领域进行了全面系统的分析,并对研究结果进行了可视化呈现。通过总结现状和预测未来趋势,本研究旨在为该领域的学者提供指导和参考。